Health-care companies rose as traders rotated back into a sector that has lagged the broad market in recent weeks.
Shares of Danish obesity drug maker Novo Nordisk fell even after the United Arab Emirates approved local commercial sales of its Wegovy weight-loss drug in pill form, the first market outside the U.S. for the pill.
Shares of Eli Lilly, whose weight-loss pill was already approved in the UAE, rose by more than 2%, returning to the green for the year to date.
The SPDR Select Sector Health Care exchange-traded fund, which tracks the health-care industry group of the S&P 500, rose by more than 0.75% but is still down about 5% for the year to date.
Write to Rob Curran at rob.curran@dowjones.com







